Sales revenues for September 2025 - komunikat spółki SOPHARMA AD (sopharma) - komunikat ESPI

Komunikat spółki

COMMON REPORT

	POLISH FINANCIAL SUPERVISION AUTHORITY
				UNI - EN REPORT No		204	/	2025
	Date of issue:		2025-10-21
	Short name of the issuer
	SOPHARMA AD
	Subject
	Sales revenues for September 2025
	Official market - legal basis
	Art. 56. 1. 2 of Act on Public Offering
	Unofficial market - legal basis
	Contents of the report:
	Sopharma AD notifies, that for September 2025 the Company recorded increase in sales of 24% compared to the same month of the previous year, incl. 10% increase in domestic sales and 38% increase in export sales. For the period from the beginning of 2025, the Company realized a 7% increase in sales, including 2% decrease in domestic sales and a 13% increase in export sales.
	Annexes
	File				Description
	SFA_Sales_Revenues_September_2025_EN_espi.pdf				Sales revenues for September 2025

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

16

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

nd

(NIP)

(REGON)

	SIGNATURE OF PERSONS REPRESENTING THE COMPANY
	Date	Name	Position / Function	Signature
	2025-10-21	Ognian Ivanov Donev	Executive Director

Nazwa jednostki:	SOPHARMA AD
Nazwa skrócona jednoskti:	SOPHARMA AD
Adres:	IlienskoShosse 16, 1220 Sofia
Telefon:	+359 2 813 42 00
Fax:	+359 2 936 02 86
NIP:	nd